Literature DB >> 17445102

Cutaneous allodynia in transformed migraine patients.

Lara Cooke1, Michael Eliasziw, Werner J Becker.   

Abstract

BACKGROUND: There is growing evidence that central sensitization plays a role in migraine pathogenesis, and that cutaneous allodynia is its clinical correlate. In headache research, allodynia has largely been studied in episodic migraine. The purpose of this investigation was to determine whether cutaneous allodynia occurs in transformed migraine, using individuals without headaches as controls.
METHODS: Fifteen patients with a diagnosis of transformed migraine and 15 control subjects with no history of headaches were included. All subjects were females between 18 and 50. Similar to the methods of Burstein et al, Von Frey hairs (VFH) were sequentially applied to territories supplied by divisions of the trigeminal nerve, cervical paraspinal muscles, trapezius muscles, ventral forearm, and lower leg to determine a pain threshold. As a milder stimulus, a cotton swab was stroked in the same locations. Each trial was repeated 3 times on 2 occasions. Group comparisons were made using the Student's t-test.
RESULTS: Mean pain thresholds were lower among migraine patients than control subjects across all test areas. The thresholds were statistically significantly lower in migraine patients than in control subjects for the 1st division of the trigeminal nerve (34.0 g versus 115.8 g, P= .035) and for the 2nd division (23.5 g versus 97.6 g, P= .039). Six patients found a cotton swab-stroke painful, compared to zero control subjects. Using a quantitative definition of allodynia, 75% of patients had allodynia to mechanical stimuli.
CONCLUSIONS: This study is the first to demonstrate allodynia in transformed migraine patients using a headache-free control population and supports the hypothesis that central sensitization plays a role in the evolution of transformed migraine.

Entities:  

Mesh:

Year:  2007        PMID: 17445102     DOI: 10.1111/j.1526-4610.2006.00717.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  31 in total

1.  Episodic and chronic migraineurs are hypersensitive to thermal stimuli between migraine attacks.

Authors:  Todd J Schwedt; Melissa J Krauss; Karen Frey; Robert W Gereau
Journal:  Cephalalgia       Date:  2010-04-07       Impact factor: 6.292

Review 2.  Sensitization, glutamate, and the link between migraine and fibromyalgia.

Authors:  Paola Sarchielli; Massimiliano Di Filippo; Katiuscia Nardi; Paolo Calabresi
Journal:  Curr Pain Headache Rep       Date:  2007-10

Review 3.  Animal models of chronic migraine.

Authors:  Robin James Storer; Weera Supronsinchai; Anan Srikiatkhachorn
Journal:  Curr Pain Headache Rep       Date:  2015-01

4.  Sinus venous stenosis-associated idiopathic intracranial hypertension without papilledema as a powerful risk factor for progression and refractoriness of headache.

Authors:  Roberto De Simone; Angelo Ranieri; Silvana Montella; Mario Marchese; Vincenzo Bonavita
Journal:  Curr Pain Headache Rep       Date:  2012-06

Review 5.  Pain cognition in migraine: from basic neurophysiology to a behavioral paradigm.

Authors:  Vincenzo Bonavita; Roberto De Simone; Angelo Ranieri
Journal:  Neurol Sci       Date:  2018-06       Impact factor: 3.307

6.  Combination of acupuncture and spinal manipulative therapy: management of a 32-year-old patient with chronic tension-type headache and migraine.

Authors:  Bahia A Ohlsen
Journal:  J Chiropr Med       Date:  2012-09

Review 7.  The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain.

Authors:  Giulia Donvito; Sara R Nass; Jenny L Wilkerson; Zachary A Curry; Lesley D Schurman; Steven G Kinsey; Aron H Lichtman
Journal:  Neuropsychopharmacology       Date:  2017-08-31       Impact factor: 7.853

8.  Evidence of persistent central sensitization in chronic headaches: a multi-method study.

Authors:  Elena Filatova; Nina Latysheva; Alexey Kurenkov
Journal:  J Headache Pain       Date:  2008-08-09       Impact factor: 7.277

9.  The effects of the TRPV1 receptor antagonist SB-705498 on trigeminovascular sensitisation and neurotransmission.

Authors:  G A Lambert; J B Davis; J M Appleby; B A Chizh; K L Hoskin; A S Zagami
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-08-19       Impact factor: 3.000

10.  Allodynia as a complication of migraine: background and management.

Authors:  William B Young
Journal:  Curr Treat Options Neurol       Date:  2009-01       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.